HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

The widespread use of the integrase strand transfer inhibitor (INSTI) dolutegravir in first-line and second-line antiretroviral therapy (ART) might facilitate emerging resistance. The DTG RESIST study combined data from HIV cohorts to examine patterns of drug resistance mutations (DRMs) and identify...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet HIV Jg. 10; H. 11; S. e733
Hauptverfasser:	Loosli, Tom, Hossmann, Stefanie, Ingle, Suzanne M, Okhai, Hajra, Kusejko, Katharina, Mouton, Johannes, Bellecave, Pantxika, van Sighem, Ard, Stecher, Melanie, d'Arminio Monforte, Antonella, Gill, M John, Sabin, Caroline A, Maartens, Gary, Günthard, Huldrych F, Sterne, Jonathan A C, Lessells, Richard, Egger, Matthias, Kouyos, Roger D
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands 01.11.2023
Schlagworte:	Cohort Studies Drug Resistance, Viral - genetics Heterocyclic Compounds, 3-Ring - pharmacology Heterocyclic Compounds, 3-Ring - therapeutic use HIV Infections - drug therapy HIV Integrase Inhibitors - pharmacology HIV Integrase Inhibitors - therapeutic use HIV Seropositivity - drug therapy HIV-1 - genetics Humans Lamivudine - therapeutic use Reverse Transcriptase Inhibitors - therapeutic use
ISSN:	2352-3018, 2352-3018
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!